Development of enzyme-linked immunosorbent assays (elisas) for ninds NIH blueprint neurotherapeutics (BPN) biologics project
Active Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $531,194
Award facts
- Opportunity
-
- 75N95023R00012 Solicitation number
- Contract value 24% obligated
-
- $531,194.00 Current, with exercised options
- $2,187,611.00 Potential, with all options
- Completion date 74% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $136,760 | |
| Supplemental Agreement for work within scope | $61,787 | |
| Supplemental Agreement for work within scope | $207,083 | |
| Original award | $125,564 |
About this award
This is a delivery order awarded to Battelle Memorial Institute by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), under a $149 million master indefinite-delivery indefinite-quantity (IDIQ) contract for manufacturing and nonclinical studies of neurological therapeutic biotechnology products. The $2,187,611 delivery order is for the development of enzyme-linked immunosorbent assays (ELISAs) in support of NINDS' Blueprint Neurotherapeutics (BPN) Biologics project. The contract does not have a set-aside designation. Battelle, a nonprofit research and development organization, frequently serves as a prime and subcontractor for federal agencies, leveraging its broad scientific and technical capabilities to support programs across domains like defense, health, and energy.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on February 7, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $531,194 on 75N95023F00001. Its potential value, with all options, is $2,187,611.
Which agency awarded contract 75N95023F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under 75N95022D00021, an indefinite delivery contract, on Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders.
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award